|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL.: (2006.01) |
A61K 31/55 C07D 403/00 |
| (11) | Number of the document | 4676 |
| (13) | Kind of document | B |
| (21) | Application number | 99-044 |
| (22) | Date of filing the application | 1999-05-03 |
| (41) | Date of publication of the application | 2000-02-25 |
| (45) | Date of publication of patent | 2000-07-25 |
| (86) | Number | PCT/US97/20035 |
| Date | 1997-11-04 |
| (87) | Number | WO 98/20008 |
| Date | 1998-05-14 |
| (30) | Number | Date | Country code |
| 029745 | 1996-11-08 | US | |
| 747104 | 1996-11-08 | US |
| (71) |
DUPONT PHARMACEUTICALS COMPANY,
Chestnut Run Plaza, 974 centre Road, Wilmington, Delaware,
US
|
| (72) |
James David RODGERS, US
Robert FrankIII KALTENBACH, US |
| (73) |
DUPONT PHARMACEUTICALS COMPANY,
Chestnut Run Plaza, 974 centre Road, Wilmington, Delaware,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | 1-(3-AMINOINDAZOL-5-YL)-3-PHENYLMETHYL-CYCLIC UREAS USEFUL AS HIV PROTEASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2000-10-06 | 4 | 320.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2001-11-04 |